SPG302 protects retinal ganglion cells and preserves visual function by preserving synaptic activity in a mouse model of glaucoma
Experimental Eye Research · 2025
DOI: 10.1016/j.exer.2025.110640 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Eye Research, 2025. Verfasst von Tonking Bastola und 9 weiteren Autor:innen. Beteiligte Einrichtung: Hamilton Glaucoma Center, and Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, CA, …. Hauptthemen laut MEDLINE: Retinal Ganglion Cells, Glaucoma, Synapses, Neuroprotective Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Glaucoma, a leading cause of irreversible vision loss worldwide, is an optic neuropathy characterized by optic nerve degeneration and retinal ganglion cell (RGC) death. Early glaucomatous damage is often associated with dendritic and synaptic abnormalities in RGCs, yet the mechanisms linking these synaptic alterations to RGC death remain unclear. In a mouse model of glaucoma, treatment with the clinical-stage, synaptogenic small molecule SPG302, a pegylated benzothiazole derivative, demonstrated neuroprotective effects, protecting RGCs and their axons in the glaucomatous retina and also improving retinal function as assessed by pattern electroretinogram testing. Elevated intraocular pressure disrupted synapses, as evidenced by reduced synaptophysin expression and homeostatic increases in Bassoon and PSD95 levels in the inner plexiform layer. SPG302 treatment effectively preserved synaptic integrity by reversing these changes. These findings highlight the therapeutic potential of SPG302 for protecting RGCs and preserving vision by modulating synaptic activity in glaucomatous neurodegeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hamilton Glaucoma Center, and Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, CA, 92039, USA.
- National Center for Microscopy and Imaging Research, Department of Neurosciences, University of California San Diego, La Jolla, CA, 92039, USA.
- Spinogenix Inc., 1801 Century Park East, Suite 2400, Los Angeles, CA, 90067, USA.
- Hamilton Glaucoma Center, and Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, CA, 92039, USA; Institute of Engineering in Medicine, Shu Chien - Gene Lay…
Förderung
- NEI NIH HHS
- National Institutes of Health
Zitieren
APA
Bastola, T., Choi, S., Shen, Z., Kim, K. Y., Vanderklish, P. W., Sarraf, S. T., Do, J. L., Huang, A. S., Weinreb, R. N., & Ju, W. K. (2025). SPG302 protects retinal ganglion cells and preserves visual function by preserving synaptic activity in a mouse model of glaucoma. Experimental Eye Research. https://doi.org/10.1016/j.exer.2025.110640
Vancouver
Bastola T, Choi S, Shen Z, Kim KY, Vanderklish PW, Sarraf ST, et al. SPG302 protects retinal ganglion cells and preserves visual function by preserving synaptic activity in a mouse model of glaucoma. Experimental Eye Research. 2025. doi:10.1016/j.exer.2025.110640
BibTeX
@article{Bastola2025,
author = {Bastola, Tonking and Choi, Seunghwan and Shen, Ziyao and Kim, Keun-Young and Vanderklish, Peter W and Sarraf, Stella T and Do, Jiun L and Huang, Alex S and Weinreb, Robert N and Ju, Won-Kyu},
title = {SPG302 protects retinal ganglion cells and preserves visual function by preserving synaptic activity in a mouse model of glaucoma},
journal = {Experimental Eye Research},
year = {2025},
doi = {10.1016/j.exer.2025.110640}
}
EUVIMED